{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:29:31Z","timestamp":1793402971335,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>War injuries are characterized by a high incidence of bone and soft tissue infections caused by multidrug-resistant (MDR) pathogens. We analyzed the influence of infections with MDR pathogens on the course and outcome of 17 Ukranian patients within the first three years of surgical therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To assess the clinical course of Ukrainian war-wounded patients treated in our tertiary care hospital between June 2022 and May 2025, the characteristics of hospital stay, number of operations, bacterial spectrum of wound infections and antibiotic therapies were analyzed retrospectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients had sustained mostly severe extremity injuries several months (105.3\u2009\u00b1\u200925.1 days) prior to admission. The average length of hospital stay was 165.6\u2009\u00b1\u200929.6 days. An average of 13\u2009\u00b1\u20093 operations were performed per patient during this time. Secondary limb amputation was required in 3\/17 patients (18%). MDR bacteria were detected in 11\/17 cases (65%). The most common pathogen (in 9\/17 patients (53%)) was carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      . The most frequently detected carbapenemase was New Delhi metallo-beta-lactamase. Due to multiple resistance, antibiotic therapy with \u2018last-resort\u2019 antibiotics such as aztreonam\/avibactam or cefiderocol was initiated in 12\/17 cases (71%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MDR pathogens and high rates of carbapenem resistance are commonly detected in war-injured patients. Traumatized patients should be given special importance in an interdisciplinary treatment concept, given the long hospital stays in a foreign country, MDR pathogens, and imminent amputation of a limb. A successful treatment frequently requires the individualized use of novel antibiotics in combination with radical surgical debridement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>III, Retrospective\/Cohort analysis<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00068-026-03116-5","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:01:40Z","timestamp":1771840900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["War injuries and antimicrobial resistance: what impact do multi-resistant pathogens have on the treatment of Ukrainian war- wounded patients?"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5665-6127","authenticated-orcid":false,"given":"Sebastian","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vakhtang","family":"Pirpilashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Osche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"M\u00f6rsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Hawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonius","family":"Pizanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Pohlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Liodakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"4","key":"3116_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jemermed.2015.03.013","volume":"49","author":"ZR Mathews","year":"2015","unstructured":"Mathews ZR, Koyfman A, Blast Injuries. J Emerg Med. 2015;49(4):573\u201387. https:\/\/doi.org\/10.1016\/j.jemermed.2015.03.013.","journal-title":"J Emerg Med"},{"issue":"4","key":"3116_CR2","doi-asserted-by":"publisher","first-page":"005338","DOI":"10.12890\/2025_005338","volume":"12","author":"J Urbieta-Mancisidor","year":"2025","unstructured":"Urbieta-Mancisidor J, Trevi\u00f1o-Theriot JM. Challenges in Managing multidrug-resistant infections among refugees: clinical experience during the Ukrainian war. Eur J Case Rep Intern Med. 2025;12(4):005338. https:\/\/doi.org\/10.12890\/2025_005338. Published 2025 Apr 2.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"3","key":"3116_CR3","doi-asserted-by":"publisher","first-page":"dlaf083","DOI":"10.1093\/jacamr\/dlaf083","volume":"7","author":"LJ Rojas","year":"2025","unstructured":"Rojas LJ, Lemonovich TL, Marshall SH, Hirschfeld A, Perez F, Bonomo RA. The price of WAR: AMR. JAC Antimicrob Resist. 2025;7(3):dlaf083. https:\/\/doi.org\/10.1093\/jacamr\/dlaf083. Published 2025 May 20.","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"3116_CR4","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/S1473-3099(24)00578-4","volume":"25","author":"ED Hermsen","year":"2025","unstructured":"Hermsen ED, Amos J, Townsend A, Becker T, Hargreaves S. Antimicrobial resistance among refugees and asylum seekers: a global systematic review and meta-analysis. Lancet Infect Dis. 2025;25(1):e34\u201343. https:\/\/doi.org\/10.1016\/S1473-3099(24)00578-4.","journal-title":"Lancet Infect Dis"},{"issue":"10325","key":"3116_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"issue":"3 Suppl","key":"3116_CR6","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1097\/TA.0b013e318163c40b","volume":"64","author":"CK Murray","year":"2008","unstructured":"Murray CK, Hinkle MK, Yun HC. History of infections associated with combat-related injuries. J Trauma. 2008;64(3 Suppl):S221\u201331. https:\/\/doi.org\/10.1097\/TA.0b013e318163c40b.","journal-title":"J Trauma"},{"key":"3116_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jhin.2024.06.011","volume":"152","author":"V Kovalchuk","year":"2024","unstructured":"Kovalchuk V, Kondratiuk V, McGann P, et al. Temporal evolution of bacterial species and their antimicrobial resistance characteristics in wound infections of war-related injuries in Ukraine from 2014 to 2023. J Hosp Infect. 2024;152:99\u2013104. https:\/\/doi.org\/10.1016\/j.jhin.2024.06.011.","journal-title":"J Hosp Infect"},{"issue":"7","key":"3116_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00113-024-01444-y","volume":"127","author":"D Bieler","year":"2024","unstructured":"Bieler D, Kollig E, Weber W, et al. Mikrobiologische herausforderungen Bei der versorgung von Kriegsverletzungen [Microbiological challenges in the treatment of war injuries]. Unfallchirurgie (Heidelb). 2024;127(7):509\u201314. https:\/\/doi.org\/10.1007\/s00113-024-01444-y.","journal-title":"Unfallchirurgie (Heidelb)"},{"key":"3116_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijid.2023.04.394","volume":"132","author":"FK Berger","year":"2023","unstructured":"Berger FK, Schmartz GP, Fritz T, et al. Occurrence, resistance patterns, and management of carbapenemase-producing bacteria in war-wounded refugees from Ukraine. Int J Infect Dis. 2023;132:89\u201392. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.394.","journal-title":"Int J Infect Dis"},{"key":"3116_CR10","unstructured":"WHO AWaRe classification of antibiotics for evaluation and monitoring of use, July, 26. 2023. Available at: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04"},{"issue":"7","key":"3116_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cmi.2024.03.029","volume":"30","author":"G Granata","year":"2024","unstructured":"Granata G, Petersen E, Capone A, et al. The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review. Clin Microbiol Infect. 2024;30(7):858\u201365. https:\/\/doi.org\/10.1016\/j.cmi.2024.03.029.","journal-title":"Clin Microbiol Infect"},{"issue":"50","key":"3116_CR12","doi-asserted-by":"publisher","first-page":"2200926","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200926","volume":"27","author":"M Sandfort","year":"2022","unstructured":"Sandfort M, Hans JB, Fischer MA, et al. Increase in NDM-1 and NDM-1\/OXA-48-producing Klebsiella pneumoniae in Germany associated with the war in Ukraine, 2022. Euro Surveill. 2022;27(50):2200926. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.50.2200926.","journal-title":"Euro Surveill"},{"issue":"2","key":"3116_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10096-020-04021-4","volume":"40","author":"S Roth","year":"2021","unstructured":"Roth S, Berger FK, Link A, et al. Application and clinical impact of the RESIST-4 O.K.N.V. Rapid diagnostic test for carbapenemase detection in blood cultures and clinical samples. Eur J Clin Microbiol Infect Dis. 2021;40(2):423\u20138. https:\/\/doi.org\/10.1007\/s10096-020-04021-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"3116_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, et al. European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521\u201347. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.025.","journal-title":"Clin Microbiol Infect"},{"key":"3116_CR15","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. August 7, 2024 Published Online August. 2024;7. https:\/\/doi.org\/10.1093\/cid\/ciae403.","DOI":"10.1093\/cid\/ciae403"},{"issue":"2","key":"3116_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/jramc-157-02-09","volume":"157","author":"HC Guthrie","year":"2011","unstructured":"Guthrie HC, Clasper JC, Kay AR, Parker PJ. Limb trauma and wounds working Groups, ADMST. Initial extremity war wound debridement: a multidisciplinary consensus. J R Army Med Corps. 2011;157(2):170\u20135. https:\/\/doi.org\/10.1136\/jramc-157-02-09.","journal-title":"J R Army Med Corps"},{"issue":"3","key":"3116_CR17","first-page":"346","volume":"45","author":"AC Masquelet","year":"2000","unstructured":"Masquelet AC, Fitoussi F, Begue T, Muller GP. Reconstruction des Os longs par membrane induite et Autogreffe spongieuse [Reconstruction of the long bones by the induced membrane and spongy autograft]. Ann Chir Plast Esthet. 2000;45(3):346\u201353.","journal-title":"Ann Chir Plast Esthet"},{"issue":"6","key":"3116_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.injury.2011.03.036","volume":"42","author":"PV Giannoudis","year":"2011","unstructured":"Giannoudis PV, Faour O, Goff T, Kanakaris N, Dimitriou R. Masquelet technique for the treatment of bone defects: tips-tricks and future directions. Injury. 2011;42(6):591\u20138. https:\/\/doi.org\/10.1016\/j.injury.2011.03.036.","journal-title":"Injury"},{"key":"3116_CR19","doi-asserted-by":"publisher","unstructured":"Masquelet AC, Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am. 2010;41(1). https:\/\/doi.org\/10.1016\/j.ocl.2009.07.011.","DOI":"10.1016\/j.ocl.2009.07.011"},{"key":"3116_CR20","doi-asserted-by":"publisher","unstructured":"\u00c4lg\u00e5 A, Wong S, Shoaib M et al. Infection with high proportion of multidrug-resistant bacteria in conflict-related injuries is associated with poor outcomes and excess resource consumption: a cohort study of Syrian patients treated in Jordan. BMC Infect Dis. 2018;18(1):233. Published 2018 May 22 https:\/\/doi.org\/10.1186\/s12879-018-3149-y","DOI":"10.1186\/s12879-018-3149-y"},{"issue":"3","key":"3116_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7205\/milmed-d-09-00075","volume":"175","author":"D Hinck","year":"2010","unstructured":"Hinck D, Franke A, Gatzka F. Use of vacuum-assisted closure negative pressure wound therapy in combat-related injuries\u2013literature review. Mil Med. 2010;175(3):173\u201381. https:\/\/doi.org\/10.7205\/milmed-d-09-00075.","journal-title":"Mil Med"},{"issue":"5","key":"3116_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/01.ta.0000241150.15342.da","volume":"61","author":"BE Leininger","year":"2006","unstructured":"Leininger BE, Rasmussen TE, Smith DL, Jenkins DH, Coppola C. Experience with wound VAC and delayed primary closure of contaminated soft tissue injuries in Iraq. J Trauma. 2006;61(5):1207\u201311. https:\/\/doi.org\/10.1097\/01.ta.0000241150.15342.da.","journal-title":"J Trauma"},{"issue":"10 Suppl","key":"3116_CR23","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1097\/BOT.0b013e318188e27d","volume":"22","author":"ET Powell","year":"2008","unstructured":"Powell ET 4. The role of negative pressure wound therapy with reticulated open cell foam in the treatment of war wounds. J Orthop Trauma. 2008;22(10 Suppl):S138\u201341. https:\/\/doi.org\/10.1097\/BOT.0b013e318188e27d.","journal-title":"J Orthop Trauma"},{"key":"3116_CR24","doi-asserted-by":"publisher","unstructured":"Franke A, Bieler D, D\u00fchr S, Friemert B, Lehmann W, Matthes G. Versorgung von Kriegsverletzten aus der Ukraine in den Traumanetzwerken der DGU \u2013 Anspruch, Wirklichkeit und Motivation im Verlauf von 18 Monaten \u2026 Treatment of the wounded from the war in Ukraine in the trauma networks of the DGU-Requirement, reality and motivation over the course of 18 months\u2026]. Unfallchirurgie (Heidelb). 2024;127(2):160\u2013168. https:\/\/doi.org\/10.1007\/s00113-023-01395-w.","DOI":"10.1007\/s00113-023-01395-w"},{"key":"3116_CR25","unstructured":"WHO: Global action plan on antimicrobial resistance, January, 16. 2016. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789241509763"},{"key":"3116_CR26","unstructured":"WHO. Capturing the evidence on access to essential antibiotics in refugee and migrant populations, September, 19, 2022. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240057807"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-026-03116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-026-03116-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-026-03116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:41:43Z","timestamp":1781635303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-026-03116-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1007\/s00068-026-03116-5","relation":{},"ISSN":["1863-9941"],"issn-type":[{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SS: Grants \/ contracts: AO-Foundation research grant; Payment or honoraria for presentations: Pfizer DO: Grants \/ contracts: AO-Foundation research grant; consulting fees: Rimasys, AO Trauma; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: AO Faculty Member, RimasysTF: Royalties or licenses: Elsevier; consulting fees: Rimasys, AO Trauma, Illuminoss; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Rimasys, IlluminossSLB: Participation on a Data Safety Monitoring Board or Advisory Board: Shionogi (regarding cefiderocol), Pfizer (regarding ceftazidime\/avibactam and aztreonam\/avibactam)TP: Grants \/ contracts: DFG, BMBF, AO-Foundation, Werner Siemens Foundation, Storz; Support for attending meetings and\/or travel: President AO Foundation, travel costs, stipend; Patents planned, issued or pending: several alongside the project \u2018smart implants\u2019 \u2013 Saarland University; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: DGU, DGOU, DGCH, AO-Foundation; stock or stock options: IlluminossAll other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}